Cargando…
Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis
Combinations of three or more drugs are used to treat many diseases, including tuberculosis. Thus, it is important to understand how synergistic or antagonistic drug interactions affect the efficacy of combination therapies. However, our understanding of high-order drug interactions is limited becau...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636204/ https://www.ncbi.nlm.nih.gov/pubmed/29026882 http://dx.doi.org/10.1126/sciadv.1701881 |
_version_ | 1783270404866965504 |
---|---|
author | Cokol, Murat Kuru, Nurdan Bicak, Ece Larkins-Ford, Jonah Aldridge, Bree B. |
author_facet | Cokol, Murat Kuru, Nurdan Bicak, Ece Larkins-Ford, Jonah Aldridge, Bree B. |
author_sort | Cokol, Murat |
collection | PubMed |
description | Combinations of three or more drugs are used to treat many diseases, including tuberculosis. Thus, it is important to understand how synergistic or antagonistic drug interactions affect the efficacy of combination therapies. However, our understanding of high-order drug interactions is limited because of the lack of both efficient measurement methods and theoretical framework for analysis and interpretation. We developed an efficient experimental sampling and scoring method [diagonal measurement of n-way drug interactions (DiaMOND)] to measure drug interactions for combinations of any number of drugs. DiaMOND provides an efficient alternative to checkerboard assays, which are commonly used to measure drug interactions. We established a geometric framework to factorize high-order drug interactions into lower-order components, thereby establishing a road map of how to use lower-order measurements to predict high-order interactions. Our framework is a generalized Loewe additivity model for high-order drug interactions. Using DiaMOND, we identified and analyzed synergistic and antagonistic antibiotic combinations against Mycobacterium tuberculosis. Efficient measurement and factorization of high-order drug interactions by DiaMOND are broadly applicable to other cell types and disease models. |
format | Online Article Text |
id | pubmed-5636204 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-56362042017-10-12 Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis Cokol, Murat Kuru, Nurdan Bicak, Ece Larkins-Ford, Jonah Aldridge, Bree B. Sci Adv Research Articles Combinations of three or more drugs are used to treat many diseases, including tuberculosis. Thus, it is important to understand how synergistic or antagonistic drug interactions affect the efficacy of combination therapies. However, our understanding of high-order drug interactions is limited because of the lack of both efficient measurement methods and theoretical framework for analysis and interpretation. We developed an efficient experimental sampling and scoring method [diagonal measurement of n-way drug interactions (DiaMOND)] to measure drug interactions for combinations of any number of drugs. DiaMOND provides an efficient alternative to checkerboard assays, which are commonly used to measure drug interactions. We established a geometric framework to factorize high-order drug interactions into lower-order components, thereby establishing a road map of how to use lower-order measurements to predict high-order interactions. Our framework is a generalized Loewe additivity model for high-order drug interactions. Using DiaMOND, we identified and analyzed synergistic and antagonistic antibiotic combinations against Mycobacterium tuberculosis. Efficient measurement and factorization of high-order drug interactions by DiaMOND are broadly applicable to other cell types and disease models. American Association for the Advancement of Science 2017-10-11 /pmc/articles/PMC5636204/ /pubmed/29026882 http://dx.doi.org/10.1126/sciadv.1701881 Text en Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (http://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited. |
spellingShingle | Research Articles Cokol, Murat Kuru, Nurdan Bicak, Ece Larkins-Ford, Jonah Aldridge, Bree B. Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis |
title | Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis |
title_full | Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis |
title_fullStr | Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis |
title_full_unstemmed | Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis |
title_short | Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis |
title_sort | efficient measurement and factorization of high-order drug interactions in mycobacterium tuberculosis |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636204/ https://www.ncbi.nlm.nih.gov/pubmed/29026882 http://dx.doi.org/10.1126/sciadv.1701881 |
work_keys_str_mv | AT cokolmurat efficientmeasurementandfactorizationofhighorderdruginteractionsinmycobacteriumtuberculosis AT kurunurdan efficientmeasurementandfactorizationofhighorderdruginteractionsinmycobacteriumtuberculosis AT bicakece efficientmeasurementandfactorizationofhighorderdruginteractionsinmycobacteriumtuberculosis AT larkinsfordjonah efficientmeasurementandfactorizationofhighorderdruginteractionsinmycobacteriumtuberculosis AT aldridgebreeb efficientmeasurementandfactorizationofhighorderdruginteractionsinmycobacteriumtuberculosis |